* Valeant $VRX once again shows there is high demand for Bausch Health bonds.* This shifts maturities of 2020 and 2021 to the 2027 year* Near-term credit risks reduced* Threat of bankruptcy diminished once again.Related: Generics are back in favor. $TEVA, $ENDP are recovering. $TEVA, Teva Pharmaceutical Industries Limited / H1 $ENDP: $ENDP, Endo International plc / H1